Literature DB >> 8290041

Megadose corticosteroids in multiple sclerosis.

M J Kupersmith, D Kaufman, D W Paty, G Ebers, H McFarland, K Johnson, S Reingold, J Whitaker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8290041     DOI： 10.1212/wnl.44.1.1

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

1.  Adherence to Clinical Trial Supported Evaluation of Optic Neuritis.

Authors:  Elana Meer; Kenneth S Shindler; Yinxi Yu; Brian L VanderBeek
Journal:  Ophthalmic Epidemiol       Date:  2019-05-29       Impact factor: 1.648

2.  Molecular diagnostic analysis for Huntington's disease: a prospective evaluation.

Authors:  J C MacMillan; P Davies; P S Harper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-04       Impact factor: 10.154

3.  The 21-aminosteroid U-74389F increases the number of glial fibrillary acidic protein-expressing astrocytes in the spinal cord of control and Wobbler mice.

Authors:  M C Gonzalez Deniselle; S L Gonzalez; G G Piroli; A E Lima; A F De Nicola
Journal:  Cell Mol Neurobiol       Date:  1996-02       Impact factor: 5.046

4.  The 21-aminosteroid U-74389F attenuates hyperexpression of GAP-43 and NADPH-diaphorase in the spinal cord of wobbler mouse, a model for amyotrophic lateral sclerosis.

Authors:  M C González Deniselle; S L González; A E Lima; G Wilkin; A F De Nicola
Journal:  Neurochem Res       Date:  1999-01       Impact factor: 3.996

5.  Fludarabine add-on therapy in interferon-beta-treated patients with multiple sclerosis experiencing breakthrough disease.

Authors:  Steven J Greenberg; Robert Zivadinov; Peterkin Lee-Kwen; Jitendra Sharma; Margaret Planter; Margaret Umhauer; Norman Glenister; Rohit Bakshi
Journal:  Ther Adv Neurol Disord       Date:  2016-01-21       Impact factor: 6.570

6.  Outcome of MS relapses in the era of disease-modifying therapy.

Authors:  Muriel Stoppe; Maria Busch; Luise Krizek; Florian Then Bergh
Journal:  BMC Neurol       Date:  2017-08-07       Impact factor: 2.474

Review 7.  Childhood multiple sclerosis: a review.

Authors:  Amy Waldman; Erin O'Connor; Gihan Tennekoon
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2006

Review 8.  Epigenetic Drugs for Multiple Sclerosis.

Authors:  Jacob Peedicayil
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.